Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Barito Pacific Placement - Well Flagged Deal but Seems to Be Priced In

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Chandra Asri Petrochemical / Equity Capital Markets

<p>Leading Indonesia petrochemical player <a href="https://www.smartkarma.com/entities/2556" target="_blank" data-smartkarma-citation="entities:2556:1">Chandra Asri Petrochemical (TPIA IJ)</a> is raising USD380m through a rights issue. 65% of the rights shares are renounced by the company's major shareholders for an institutional placement.  In our insight, we will look at the recent development of the company, impact of the deal and score the deals in our ECM Framework. </p><h2>Placement specifics</h2><ul>
<li>Company Name: Chandra Asri Petrochemical Tbk PT</li>
<li>Ticker: TPIA IJ</li>
<li>Right share placement &amp; Accelerated Bookbuild</li>
<li>Settlement is…</li>
</ul>

Leading Indonesia petrochemical player Chandra Asri Petrochemical (TPIA IJ) is raising USD380m through a rights issue. 65% of the rights shares are renounced by the company's major shareholders for an institutional placement.  In our insight, we will look at the recent development of the company, impact of the deal and score the deals in our ECM Framework. Placement specifics
Company Name: Chandra Asri Petrochemical Tbk PT
Ticker: TPIA IJ
Right share placement &amp; Accelerated Bookbuild
Settlement is…


PT Chandra Asri Placement: Deserves Premium for Strong Fundamentals and Leadership